Robert Hayman - Jan 24, 2022 Form 4 Insider Report for Evolus, Inc. (EOLS)

Role
Director
Signature
/s/ Jeffrey J. Plumer, as attorney-in-fact for Robert Hayman
Stock symbol
EOLS
Transactions as of
Jan 24, 2022
Transactions value $
$0
Form type
4
Date filed
1/26/2022, 08:00 PM
Next filing
Sep 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EOLS Common Stock Award $0 +15.6K +80.61% $0.00 34.9K Jan 24, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EOLS Stock Option (Right to Buy) Award $0 +22.7K $0.00 22.7K Jan 24, 2022 Common Stock 22.7K $5.46 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of January 24, 2022, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer
F2 The shares subject to the option will vest as to 1/12 of the underlying shares monthly from the vesting commencement date of January 24, 2022, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.